Home Vium

Vium

acquired
Series B
Translational Medicine Technology Developer

Basic Information

Vium is a translational medicine company focused on improving the success rate of drug development. By creating more precise and reproducible disease models, Vium's digital platform provides physiological biomarkers that can better determine which compounds should advance to clinical trials. Vium's Digital Vivarium™ and Vium Cloud are gold-standard in vivo platforms that integrate computer vision, artificial intelligence, machine learning, and sensor technologies to non-invasively collect and analyze digital biomarker insights. The Vium platform continuously captures physiological parameters and behaviors non-invasively, offering more sensitive and accurate data collection, thereby enabling more reproducible research. By providing researchers with these continuous, rich datasets, the platform allows them to identify which digital biomarkers or combinations of biomarkers are the strongest indicators of disease.
Vium, Inc.
California,United States of America
51~100 people
January 01, 2013
info@vium.com